Publication | Closed Access

(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo

Medicinal ChemistryMedicineImmunosuppressive TherapyImmunologyTherapeutic EfficacyBiological TherapyImmunotherapyPharmacologyNovel TherapyDrug Discovery